Additionally, IHC staining data in the HPA dataset suggested an extremely low positive expression rate of RPF2 in common RCC types, further indicating that RPF2 might become a specific diagnostic and therapeutic target for CDC. This evidence concerns the gene RPF2 and renal cell carcinoma.